The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

Press release from Business Wire

Sanofi FY 2012 - Interview with CEO Chris Viehbacher

Thursday, February 07, 2013

Sanofi FY 2012 - Interview with CEO Chris Viehbacher01:45 EST Thursday, February 07, 2013 PARIS (Business Wire) -- Sanofi, a global and diversified healthcare leader, reports 2012 results. CEO Chris Viehbacher comments on 2012 results and outlook for 2013. Click to watch the video: http://bit.ly/XkZjhU Topics covered in the interview include: - 2012 Results- Genzyme- Emerging Markets- Diabetes franchise- R&D Pipeline- Animal Health- Capital Allocation- Cost savings- 2013 Guidance About Sanofi Sanofi, a global and diversified healthcare leader, discovers, develops and distributes therapeutic solutions focused on patients' needs. Sanofi has core strengths in the field of healthcare with seven growth platforms: diabetes solutions, human vaccines, innovative drugs, consumer healthcare, emerging markets, animal health and the new Genzyme. Sanofi is listed in Paris (EURONEXT: SAN) and in New York (NYSE: SNY). Company website: www.sanofi.com SanofiInvestor Relations:Sébastien Martel, +33 1 53 77 45 45IR@sanofi.comorMedia Relations:+33 1 53 77 45 02MR@sanofi.com